BioNTech SE
Status: Publicly traded
Direct answer
BioNTech SE is publicly traded on NASDAQ under the ticker BNTX.
BioNTech SE, a biotechnology firm, specializes in the creation and marketing of immune-based treatments for malignancies and various infectious diseases. A significant part of its oncology pipeline includes the FixVac cancer vaccine program, which features several candidates in different phases of clinical development: BNT111 is in Phase 2 for advanced melanoma. BNT112 has reached Phase 1/2a for prostate cancer....
Can you invest in BioNTech SE?
Yes. BioNTech SE is publicly traded on NASDAQ under the ticker BNTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.